Alyglo: payments to doctors
Payments that named Alyglo as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $72K
- Providers
- 461
- Transactions
- 880
- Average per transaction
- $82
The per-transaction average — $82 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 461 providers the average total is $157, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| GC Biopharma USA, Inc. | $72,154 | 99.8% |
| GC Biopharma Corp. | $111 | 0.2% |